The invention disclosed herein is a process for increasing the desired concentration of a pharmaceutically active ingredient relative to fill composition viscosity for dosage units. The process is particularly useful in the preparation of soft gelatin capsules containing pharmaceutically active ingredient. As a resu...
The present invention discloses a lubricating unit/apparatus/system and to the method of lubricating encapsulated soft gelatine capsules and, more particularly, to soft gelatin and non-gelatin capsules to overcome the problem of clumping and nesting of the soft gelatin capsules.
The present invention discloses stable oral lozenges containing nicotine active which is bioequivalent to approved marketed lozenges as nicotine replacement therapy for reducing or stopping tobacco usage.
Instrument(s) of creation or modification of charge;-02122020
Form CHG-1-02122020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20201202
Optional Attachment-(1)-01122020
Optional Attachment-(2)-01122020
Optional Attachment-(3)-01122020
Copy of court order or NCLT or CLB or order by any other competent authority.-01122020
Form MSME FORM I-22112020_signed
Form MSME FORM I-21112020_signed
Form MSME FORM I-20112020_signed
Form MSME FORM I-20112020
Form PAS-3-11112020_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-11112020
Copy of Board or Shareholders? resolution-11112020
Instrument(s) of creation or modification of charge;-11112020
Form CHG-1-11112020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20201111
Form MGT-6-25102020_signed
-23102020
Form MGT-7-20102020_signed
Form DPT-3-19102020-signed
Optional Attachment-(1)-19102020
List of share holders, debenture holders;-19102020